Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker

British Journal of Cancer

Volumn 87, Issue 4, 2002, Pages 414-422

  Salazar Onfray, F ^a   Lopez M ^a   Lundqvist, A ^b   Aguirre, A ^a   Escobar, A ^a   Serrano, A ^a   Korenblit, C ^a   Petersson, M ^b   Chhajlani, V ^c   Larsson, O ^b   Kiessling, R ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b Cancer Centre Karolinska   (Sweden)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Dendritic cells; Melanocortin I receptor; Melanoma antigen; Tumour immunology; Tumour marker

Indexed keywords

MELANOCORTIN 1 RECEPTOR; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADRENAL MEDULLA; ARTICLE; BLOOD CELL; CANCER CELL CULTURE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CEREBELLUM; CONTROLLED STUDY; DENDRITIC CELL; DISEASE MARKER; ENCEPHALITIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LEUKEMIA CELL LINE; LIVER; MACROPHAGE ACTIVATION; MELANOMA; MONOCYTE; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN INFLAMMATION; TISSUE DISTRIBUTION;

HUMANS; MELANOMA; MONOCYTES; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 18544367370     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600441     Document Type: Article

References (55)

1. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation
2. Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation
3. Dendritic cells and the control of immunity
4. Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R
5. Evidence for the differential expression of functional a-melanocyte-stimulating hormone receptor MC-1 on human monocytes
6. Proopiomelanocortin and the immune-neuroendocrine connection
7. The tyrosine gene coded for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 + melanoma
8. Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage
9. Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)
10. Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other stereoid tumors
11. Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: Evidence for increased expression of POMC peptides near suprabasal layer of epidermis
12. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA
13. Molecular cloning of a novel human melanocortin receptor
14. Distribution of cDNA for melanocortin receptor subtypes in human tissues
15. Detection of cytoplasmic S-100 protein in primary and metastatic intraocular melanomas
16. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
17. Human keratinocytes express functional alpha-MSH (MC1-R) receptors
18. Thyl+ dentritic cells express truncated form of POMC mRNA
19. Alpha-MSH causes a small rise in cAMP but has no effect on basal or ultraviolet-stimulated melanogenesis in human melanocytes
20. Molecular cloning, expression, and gene localisation of a fourth melanocortin receptor
21. Molecular cloning of a novel melanocortin receptor
22. Regulation of tyrosinase in human melanocytes grown in culture
23. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea; Comparison of the novel antibody against mela-A with S100 protein and HMB-45
24. Regulation of mammalian melanogenesis by tyrosinase inhibition
25. Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes
26. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection
27. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
28. Identification of the immunodominant peptides of the Mart-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes
29. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor infiltrating T lymphocytes associated with in vivo tumor regression
30. Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study
31. The role of alpha-MSH as modulator of cutaneous inflammation
32. Production and characterization of monoclonal antibody to a melanoma specific glycoprotein
33. The cloning of a family of genes that encode the melanotropin receptor
34. Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic host
35. Melan-A/MART-1 antigen expression in cutaneous and ocular melanomas
36. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan
37. Alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line
38. Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide
39. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
40. Synthetic peptides derived from the melanocyte stimulating hormone receptor MC1R can stimulate HLA-A2 restricted CTL that recognize naturally processed peptides on human melanoma cells
41. Efficient presentation of soluble antigen by cultured human dentritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor alpha
42. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB hybrid
43. Consequences of cell death: Exposure to necrotic tumor cells but not primary tissue or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
44. Propio-melanocortin derived peptides are synthesized and released by human keratinocytes
45. Correlation of chondroitin sulfate proteoglycan expression proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells
46. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: Implications for pigmentation and proliferation
47. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
48. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-MSH
49. Binding of melanotropic hormones to the melanoconin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis
50. Melanotropin receptors demonstrated in situ in human melanoma
51. Immunohistochemical detection of the melanocortin 1 receptor in human testis, ovary, and placenta using specific monoclonal antibody
52. Non-random distribution of receptors for melanocyte-stimulating hormone on the surface of mouse melanoma cells
53. Immunological localisation of melanocortin 1 receptor on the cell surface of WM266-4 human melanoma cells
54. The HLA-A.B 'Negative' mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon